Skip to main navigation
Skip to search
Skip to main content
Luxembourg Institute of Health Home
Home
Profiles
Research units
Research output
Projects
Equipment
Datasets
Search by expertise, name or affiliation
Clinical presentation and management of drug-induced agranulocytosis
Emmanuel Andrès
*
, Jacques Zimmer
, Mustapha Mecili
, Thierry Weitten
, Martine Alt
, Frédéric Maloisel
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
Research
›
peer-review
58
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Clinical presentation and management of drug-induced agranulocytosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Drug-induced Agranulocytosis
100%
Neutrophil Count
100%
Drug-induced
50%
Granulocyte Colony-stimulating Factor (G-CSF)
50%
Septicemia
50%
Appropriate Management
50%
Renal Failure
50%
Hematopoietic Growth Factors
50%
Metabolic Disorders
50%
Broad-spectrum Antibiotics
50%
Modern Management
50%
Medicine and Dentistry
Agranulocytosis
100%
Neutrophil
100%
Mortality Rate
50%
Prognostic Factor
50%
Granulocyte Colony Stimulating Factor
50%
Hemopoietic Growth Factor
50%
Broad-Spectrum Antibiotic
50%
Septicemia
50%
Renal Failure
50%
Diseases
50%
Metabolic Disorder
50%
Pharmacology, Toxicology and Pharmaceutical Science
Agranulocytosis
100%
Antibiotics
50%
Mortality Rate
50%
Kidney Failure
50%
Hemopoietic Growth Factor
50%
Septicemia
50%
Granulocyte Colony Stimulating Factor
50%
Diseases
50%